Log In
Print this Print this

Hyalomatrix PA

  Manage Alerts
Collapse Summary General Information
Company addmedica S.A.S.
DescriptionDermal substitute made of HYAFF, a long acting derivative of hyaluronic acid
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentMarketed
Standard IndicationWounds
Indication DetailsTreat wounds
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today